Burden of bronchiectasis in indigenous peoples - How can it be improved?

Current Pediatric Reviews

Volumn 5, Issue 4, 2009, Pages 198-206

  Munro, Karen ^a   Singleton, Rosalyn J ^b   Edwards, Elizabeth A ^a   Redding, Gregory J ^c   Chang, Anne B ^d   Byrnes, Catherine A ^a,e  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bronchiectasis; Children; Chronic cough; Chronic respiratory disease; Indigenous; Pneumonia; Poverty

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT;

ABORIGINE; ARTICLE; ASTHMA; AUSTRALIA; BRONCHIECTASIS; CHILD HEALTH CARE; CHRONIC RESPIRATORY TRACT DISEASE; COUGHING; CYSTIC FIBROSIS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH PROMOTION; HEALTH SERVICE; IMMUNIZATION; INDIGENOUS PEOPLE; INFECTION; LOBECTOMY; MAORI; MORBIDITY; MORTALITY; NEW ZEALAND; NUTRITIONAL DEFICIENCY; OTITIS MEDIA; PATIENT ADVOCACY; PATIENT REFERRAL; PNEUMONIA; POSTURAL DRAINAGE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; UNITED STATES;

EID: 77954330570     PISSN: 15733963     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339609791317342     Document Type: Article

References (68)

1. Kolbe J, Wells AU. Bronchiectasis: A neglected cause ofrespiratory morbidity and mortality. Respirology 1996; 1(4): 221-5.
2. Ministry of Health. The Health of Pacific Island People. NewZealand Wellington, 1994.
3. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non-CFbronchiectasis: Clinical and HRCT evaluation. Pediatr Pulmonol2003; 35(6): 477-83.
4. Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis inthe twenty-first century: Experience of a tertiary children's hospitalin New Zealand. J Paediatr Child Health 2003; 39(2): 111-7.
5. Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand nationalincidence of bronchiectasis too high for a developed country.Arch Dis Child 2005; 90(7): 737-40.
6. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaskanative children: Causes and clinical courses. Pediatr Pulmonol2000; 29(3): 182-7.
7. Thomas DR. Assessing ethnicity in New Zealand health research.NZ Med J 2001; 114(1127): 86-8.
8. Fleshman JK, Wilson JF, Cohen JJ. Bronchiectasis in Alaska nativechildren. Arch Environ Health 1968; 17(4): 517-23.
9. Nikolaizik WH, Warner JO. Aetiology of chronic suppurative lungdisease. Arch Dis Child 1994; 70(2): 141-2.
10. Redding G, Singleton R, Lewis T, et al. Early radiographic andclinical features associated with bronchiectasis in children. PediatrPulmonol 2004; 37(4): 297-304.
11. d'Espainet ET KK, Paterson BA, Measey ML. From infancy toyoung adulthood: Health status in the northern territory. Darwin,Australia: Territory Health Services 1998.
12. Mortality of Aboriginal and Torres Straits Islander Australians: Australian Bureau of Statistics 2000.
13. National summary of the 2003 & 2004 jurisdictional reports againstthe Aboriginal and Torres Strait Islander health performanceindicators: Australian Institute of Health and Welfare 2006.
14. Occasional Paper. Hospital Statistics-Mortality of Aboriginal and Torres Strait Islander Australians 2002.
15. Aboriginal and Torres Straits Islander Health Survey: AustralianBureau of Statistics 2006.
16. Chang AB, Boyce NC, Masters IB, Torzillo PJ, Masel JP.Bronchoscopic findings in children with non-cystic fibrosis chronicsuppurative lung disease. Thorax 2002; 57(11): 935-8.
17. Steinfort DP, Brady S, Weisinger HS, Einsiedel L. Bronchiectasisin Central Australia: a young face to an old disease. Respir Med2008; 102(4): 574-8.
18. Valery PC, Torzillo PJ, Mulholland K, Boyce NC, Purdie DM,Chang AB. Hospital-based case-control study of bronchiectasis inindigenous children in Central Australia. Pediatr Infect Dis J 2004;23(10): 902-8.
19. Hinds JR. Bronchiectasis in Maori. N Z Med J 1958; 57: 328-32.
20. Saynajakangas O, Keistinen T, Tuuponen T, Kivela SL.Bronchiectasis in Finland: trends in hospital treatment. Respir Med1997; 91(7): 395-8.
21. Edwards EA, Metcalfe R, Milne DG, Thompson J, Byrnes CA.Retrospective review of children presenting with non cystic fibrosisbronchiectasis: HRCT features and clinical relationships. PediatrPulmonol 2003; 36(2): 87-93.
22. Becroft DM. Histopathology of fatal adenovirus infection of therespiratory tract in young children. J Clin Pathol 1967; 20(4): 561-9.
23. Becroft DM. Bronchiolitis obliterans, bronchiectasis, and othersequelae of adenovirus type 21 infection in young children. J ClinPathol 1971; 24(1): 72-82.
24. Becroft DM. Pulmonary sequelae of epidemic type 21-adenovirusinfection: a 13-year follow-up. Arch Dis Child 1979; 54: 155-6.
25. Waite D, Wakefield JS, Steele R, Mackay J, Ross I, Wallace J.Cilia and sperm tail abnormalities in Polynesian bronchiectatics.Lancet 1978; 2(8081): 132-3.
26. Wakefield S, Waite D. Abnormal cilia in Polynesians withbronchiectasis. Am Rev Respir Dis 1980; 121(6): 1003-10.
27. Waite DA, Wakefield SJ, Mackay JB, Ross IT. Mucociliarytransport and ultrastructural abnormalities in Polynesianbronchiectasis. Chest 1981; 80(6 Suppl): 896-8.
28. Waite DA, Wakefield SJ, Moriarty KM, Lewis ME, Cuttance PC,Scott AG. Polynesian bronchiectasis. Eur J Respir Dis Suppl 1983;127: 31-6.
29. Edwards EA, Douglas C, Broome S, et al. Nitric oxide levels andciliary beat frequency in indigenous New Zealand children. PediatrPulmonol 2005; 39(3): 238-46.
30. Twiss J, Stewart AW, Byrnes CA. Longitudinal pulmonaryfunction of childhood bronchiectasis and comparison with cysticfibrosis. Thorax 2006; 61(5): 414-8.
31. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Workinggroup on indigenous paediatric respiratory. Bronchiectasis inindigenous children in remote Australian communities. Med J Aust2002; 177(4): 200-4.
32. Grant CC, Wall CR, Brunt D, Crengle S, Scragg R. Populationprevalence and risk factors for iron deficiency in Auckland, NewZealand. J Paediatr Child Health 2007; 43(7-8): 532-8.
33. Wood L, Santibanez T, Barker L, Singelton R. Vaccinationcoverage levels among Alaska native children aged 19-35 months -National Immunization Survey: United States, 2000-2001. MorbMortal Wkly Rep 2003; 52(30): 710-3.
34. Relationship between In-Home Water Service and LowerRespiratory Infections - Alaska 1999-2002. State of Alaska:Department of Health and Human Services 2007.
35. Grant CC, Scragg R, Tan D, Pati A, Aickin R, Yee RL.Hospitalization for pneumonia in children in Auckland, NewZealand. J Paediatr Child Health 1998; 34(4): 355-9.
36. Chang AB, Masel JP, Boyce NC, Torzillo PJ. Respiratorymorbidity in central Australian Aboriginal children with alveolarlobar abnormalities. Med J Austr 2003; 178(10): 490-4.
37. Field CE. Bronchiectasis in childhood; Clinical survey of 160cases. Pediatrics 1949; 4(1): 21-46.
38. Field CE. Bronchiectasis. Third report on a follow-up study ofmedical and surgical cases from childhood. Arch Dis Child 1969;44(237): 551-61.
39. Ip M, Lam WK, So SY, Liong E, Chan CY, Tse KM. Analysis offactors associated with bronchial hyperreactivity to methacholine inbronchiectasis. Lung 1991; 169(1): 43-51.
40. Ip MS, So SY, Lam WK, Yam L, Liong E. High prevalence ofasthma in patients with bronchiectasis in Hong Kong. Eur Respir J1992; 5(4): 418-23.
41. Bahous J, Cartier A, Pineau L, et al. Pulmonary function tests andairway responsiveness to methacholine in chronic bronchiectasis ofthe adult. Bull Eur Physiopathol Respir 1984; 20(4): 375-80.
42. Varpela E, Laitinen LA, Keskinen H, Korhola O. Asthma, allergyand bronchial hyper-reactivity to histamine in patients withbronchiectasis. Clin Allergy 1978; 8(3): 273-80.
43. Singleton RJ, Redding GJ, Lewis TC, et al. Sequelae of severerespiratory syncytial virus infection in infancy and early childhoodamong Alaska Native children. Pediatrics 2003; 112(2): 285-90.
44. Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis:Still a problem. Pediatr Pulmonol 2001; 32(2): 175-8.
45. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic-fibrosis bronchiectasis in children: a persisting problem indeveloping countries. Respiration 2005; 72(3): 233-8.
46. Karakoc FDEGI, Bakac S, Yuksal M, Kiyan G, Dagli TE. Theoutcome and long-term follow-up of children wth bronchiectasis.Eur Respir J 1997; 10: 171S. (Abstract only).
47. Watson K, Carville K, Bowman J, et al. Upper respiratory tractbacterial carriage in Aboriginal and non-Aboriginal children in asemi-arid area of Western Australia. Pediatr Infect Dis J 2006;25(9): 782-90.
48. Leach AJ. Otitis media in Australian aboriginal children: Anoverview. Int J Pediatr Otorhinolaryngol 1999; 49(Suppl 1): S173-8.
49. Gursel G. Does coexistence with bronchiectasis influence intensivecare unit outcome in patients with chronic obstructive pulmonarydisease? Heart Lung 2006; 35(1): 58-65.
50. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis,exacerbation indices, and inflammation in chronic obstructivepulmonary disease. Am J Respir Crit Care Med 2004; 170(4): 400-7.
51. Eastham KM, Fall AJ, Mitchell L, Spencer DA. The need toredefine non-cystic fibrosis bronchiectasis in childhood. Thorax2004; 59(4): 324-7.
52. Tsao PC, Lin CY. Clinical spectrum of bronchiectasis in children.Acta Paediatrica Taiwanica 2002; 43(5): 271-5.
53. Lai SH, Wong KS, Liao SL. Clinical analysis of bronchiectasis inTaiwanese children. Chang Gung Med J 2004; 27(2): 122-8.
54. Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: Doesknowing the aetiology lead to changes in management? [seecomment]. Eur Respir J 2005; 26(1): 8-14.
55. Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchialdilatation in children: Comparison of serial high-resolutioncomputer tomography scans of the lungs. Eur J Radiol 2003; 47(3):215-20.
56. Mansour Y, Beck R, Danino J, Bentur L. Resolution of severebronchiectasis after removal of long-standing retained foreignbody. Pediatr Pulmonol 1998; 25(2): 130-2.
57. Rosen MJ. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 Suppl): 122S-31S.
58. Edwards EA, Twiss J, Byrnes CA. Treatment of paediatric non-cystic fibrosis bronchiectasis. Expert Opin Pharmacother 2004;5(7): 1471-84.
59. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ.Bronchiectasis in indigenous children in remote Australiancommunities. Med J Austr 2002; 177: 200-4.
60. Kerem E, Conway S, Elborn S, Heijerman H, Consensus C.Standards of care for patients with cystic fibrosis: a Europeanconsensus. J Cyst Fibros 2005; 4(1): 7-26.
61. Bush A, Cole P, Hariri M, et al. Primary ciliary dyskinesia:Diagnosis and standards of care. Eur Respir J 1998; 12(4): 982-8.
62. Chang AB, Landau LI, Van Asperen PP, et al. Cough in children:Definitions and clinical evaluation. Med J Austr 2006; 184(8): 398-403.
63. Pink R. Bronchiectasis: disease of the impoverished? [Mastersthesis]. Christchurch School of Medicine: University of Otago2004.
64. Durie M. Providing health services to indigenous peoples. BMJ2003; 327(7412): 408-9.
65. Chang AB, Taylor B, Masters IB, Laifoo Y, Brown AD.Indigenous healthcare worker involvement for Indigenous adultsand children with asthma. Cochrane Database Syst Rev 2007; (4):CD006344.
66. Bailey EJM, Kruske PS, Cates S, Chang AB. Culture-specificprogramms for children and adults from minority groups who haveasthma. Cochrane Database Syst Rev 2008(2).
67. Byrnes CAE. Outcomes in children treated for persistent bacterialbronchitis. Thorax 2007; 62: 80-4.
68. Chang AB, Redding GJ, Everard ML. Chronic wet cough:Protracted bronchitis, chronic suppurative lung disease andbronchiectasis. Pediatr Pulmonol 2008; 43(6): 519-31.